Rani Therapeutics Holdings, Inc. (RANI) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $18.62M | +394.9% |
| 2024 | $3.76M | -35.8% |
| 2023 | $5.86M | -78.3% |
| 2022 | $27.01M | -77.0% |
| 2021 | $117.45M | +60.8% |
| 2020 | $73.06M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $18.62M | +394.9% |
| 2024 | $3.76M | -35.8% |
| 2023 | $5.86M | -78.3% |
| 2022 | $27.01M | -77.0% |
| 2021 | $117.45M | +60.8% |
| 2020 | $73.06M | — |